How Does U.S. Pharma Target China Accurately for Expansion? Cypin Production’s Pharma Market Forecasting for China Workshop Offers Advice Like This.

Philadelphia, PA, October 12, 2011 --(PR.com)-- “With a GDP of more than $8 trillion, China is poised to become the world’s third-largest pharmaceutical market by 2013. To successfully meet potential demand and supply for products, accurate forecasting is essential for companies who want to break into China,” says Judy Tsui. Tsui is director of Cypin Production, a leading new company with an expertise in bringing U.S. and China biopharmaceuticals expert.

To this end, Cypin is hosting Pharma Market Forecasting for China, a full-day workshop providing insights on the unique challenges on forecasting U.S. pharmaceutical company’s access into China, as well as being a viable method for companies in China that are aiming to enhance their own domestic growth plans. The conference will be held on November 3, 2011 at the Hub CityView in Philadelphia, PA.

The Pharma Market Forecasting for China workshop will help give China a more prominent role in U.S. pharma’s forecasting and give industry experts the tools to make a better all ‘round forecast.

The workshop’s experts—which include forecasting leaders from companies such as Draco Healthcare Consulting, Kantar Health, Vifor Pharma, Sanofi-Aventis, and Insight Strategy Advisors—will address some of the forecasting complexities common to all emerging markets and specifically those unique to China.

Among the topics to be discussed will be: accurate forecasting despite lack of available quality data and ways to fill in the gaps; making predictions on possible product market access based on China’s history of imports, and who is likely to comprise China’s upcoming consumer markets.

Besides VPs, directors, managers and analysts from forecasting, marketing, strategic planning, market research/analysis and business analysts, this workshop is also recommended to business unit leaders and any person responsible for penetrating the Asia-Pacific region. The will be able to participate in numerous interactive workshops in which they’ll share current best forecasting practices and strategies designed to tackle specific complexities of China pharma market forecasting.

For more information on Pharma Market Forecasting for China, or to register for the workshop, please visit http://www.chinamarketforecast.com.

For media requests, more information on Cypin Production, or if you are interested in sponsoring, exhibiting, or speaking opportunities with Cypin, please contact Judy Tsui at 917-338-7778 or judy@cypinproduction.com.

About Cypin Production
Cypin Production is a third-party organizer that brings together government officials, leading biopharma practitioners, and academics in both China and America to share insights, expertise and solutions to today's escalating challenges in this industry. The company name is inspired by Cypin, a protein discovered by Rutgers scientists in 2004 that regulates nerve cell and neuron branching in the brain, an important process in helping people learn. Cypin makes a different kind of connection: bringing together potential buyers and sellers at our targeted conferences in emerging pharmaceutical/life science areas by providing face-to-face business opportunities and practical industry solutions for industry leaders through conferences and meetings.

###
Contact
CYPIN PRODUCTION LLC
Judy Tsui
917-338-7778
www.cypinproduction.com
ContactContact
Categories